Vaxart, Inc.
VXRT
$0.40
-$0.0155-3.73%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 288.94% | 303.27% | 577.76% | 1,174.75% | 6,796.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 288.94% | 303.27% | 577.76% | 1,174.75% | 6,796.26% |
| Cost of Revenue | 8.91% | -10.33% | -18.63% | -18.12% | -15.93% |
| Gross Profit | 25.10% | 29.02% | 34.09% | 28.28% | 24.93% |
| SG&A Expenses | -7.99% | -5.91% | -11.14% | -20.97% | -23.15% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.70% | -9.26% | -16.84% | -18.87% | -17.85% |
| Operating Income | 20.46% | 23.18% | 28.48% | 26.35% | 24.46% |
| Income Before Tax | 18.87% | 18.92% | 25.25% | 24.37% | 23.67% |
| Income Tax Expenses | -0.38% | 150.49% | 248.75% | 264.47% | 289.55% |
| Earnings from Continuing Operations | 18.82% | 18.73% | 25.03% | 24.17% | 23.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 18.82% | 18.73% | 25.03% | 24.17% | 23.47% |
| EBIT | 20.46% | 23.18% | 28.48% | 26.35% | 24.46% |
| EBITDA | 23.13% | 26.30% | 31.87% | 29.97% | 28.51% |
| EPS Basic | 40.40% | 35.04% | 38.07% | 34.68% | 30.84% |
| Normalized Basic EPS | 40.47% | 37.27% | 39.92% | 36.43% | 32.64% |
| EPS Diluted | 40.25% | 34.90% | 37.96% | 34.68% | 30.84% |
| Normalized Diluted EPS | 40.47% | 37.27% | 39.92% | 36.43% | 32.64% |
| Average Basic Shares Outstanding | 42.18% | 29.43% | 21.39% | 15.79% | 11.35% |
| Average Diluted Shares Outstanding | 42.18% | 29.43% | 21.39% | 15.79% | 11.35% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |